Austrian Myeloid Registry

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorArbeitsgemeinschaft medikamentoese Tumortherapie

About this trial

The Austrian Myeloid Registry (aMYELOIDr) is a non-interventional study. It collects data from patients with the myeloid diseases, primarily myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) and acute myeloid leukemia (AML).The aMYELOIDr is multi-center database collecting data at various sites in Austria and potentially also at other centers in other countries in future. The registry has an electronic case report form (eCRF), where all data is entered by clinical trial personnel and/or physicians. It is set up to collect real-world experience in the management of patients with these diseases in Austria.

Eligibility criteria

Qualifiers

Age >17 years

Diagnosis of myeloid disease according to WHO 2016

Signed patient informed consent (IC)

Disqualifiers

Patient is unable or unwilling to sign IC

Trial design

Treatments tested in this trial

  • Non-interventional

Treatment groups

3,000 Participants
are divided into 4 treatment groups